๐Ÿ’พ Data Updated: 2025 HTS Revision 30 โ€ข Last updated: November 24, 2025

2925.29.20.00 - Drugs

Details

FieldValue
Unit of Quantitykg
General Rate of Duty6.5%
Special Rate of DutyFree (A+,AU,BH,CL,CO,D, E,IL,JO, K,KR,MA,OM,P, PA,PE,S,SG)
A+ ๐Ÿ‡ฆ๐Ÿ‡ซ ๐Ÿ‡ฆ๐Ÿ‡ด ๐Ÿ‡ง๐Ÿ‡ฏ ๐Ÿ‡ง๐Ÿ‡น ๐Ÿ‡ง๐Ÿ‡ซ ๐Ÿ‡ง๐Ÿ‡ฎ ๐Ÿ‡ฐ๐Ÿ‡ญ ๐Ÿ‡จ๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ฉ ๐Ÿ‡ฐ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฉ ๐Ÿ‡ฉ๐Ÿ‡ฏ ๐Ÿ‡ช๐Ÿ‡น ๐Ÿ‡ฌ๐Ÿ‡ฒ ๐Ÿ‡ฌ๐Ÿ‡ณ ๐Ÿ‡ฌ๐Ÿ‡ผ ๐Ÿ‡ญ๐Ÿ‡น ๐Ÿ‡ฐ๐Ÿ‡ฎ ๐Ÿ‡ฑ๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡ฌ ๐Ÿ‡ฒ๐Ÿ‡ผ ๐Ÿ‡ฒ๐Ÿ‡ฑ ๐Ÿ‡ฒ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡ฟ ๐Ÿ‡ฒ๐Ÿ‡ฒ ๐Ÿ‡ณ๐Ÿ‡ต ๐Ÿ‡ณ๐Ÿ‡ช ๐Ÿ‡ท๐Ÿ‡ผ ๐Ÿ‡ผ๐Ÿ‡ธ ๐Ÿ‡ธ๐Ÿ‡ณ ๐Ÿ‡ธ๐Ÿ‡ฑ ๐Ÿ‡ธ๐Ÿ‡ง ๐Ÿ‡ธ๐Ÿ‡ด ๐Ÿ‡ธ๐Ÿ‡ธ ๐Ÿ‡ธ๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ฑ ๐Ÿ‡น๐Ÿ‡ฌ ๐Ÿ‡น๐Ÿ‡ป ๐Ÿ‡บ๐Ÿ‡ฌ ๐Ÿ‡ป๐Ÿ‡บ ๐Ÿ‡พ๐Ÿ‡ช ๐Ÿ‡ฟ๐Ÿ‡ฒ
AU ๐Ÿ‡ฆ๐Ÿ‡บ
BH ๐Ÿ‡ง๐Ÿ‡ญ
CL ๐Ÿ‡จ๐Ÿ‡ฑ
CO ๐Ÿ‡จ๐Ÿ‡ด
D ๐Ÿ‡ฆ๐Ÿ‡ด ๐Ÿ‡ง๐Ÿ‡ฏ ๐Ÿ‡ง๐Ÿ‡ผ ๐Ÿ‡ง๐Ÿ‡ซ ๐Ÿ‡จ๐Ÿ‡ป ๐Ÿ‡จ๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ฉ ๐Ÿ‡ฐ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฎ ๐Ÿ‡จ๐Ÿ‡ฉ ๐Ÿ‡ฉ๐Ÿ‡ฏ ๐Ÿ‡ธ๐Ÿ‡ฟ ๐Ÿ‡ช๐Ÿ‡น ๐Ÿ‡ฌ๐Ÿ‡ฆ ๐Ÿ‡ฌ๐Ÿ‡ฒ ๐Ÿ‡ฌ๐Ÿ‡ญ ๐Ÿ‡ฌ๐Ÿ‡ณ ๐Ÿ‡ฌ๐Ÿ‡ผ ๐Ÿ‡ฐ๐Ÿ‡ช ๐Ÿ‡ฑ๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡ฌ ๐Ÿ‡ฒ๐Ÿ‡ผ ๐Ÿ‡ฒ๐Ÿ‡ฑ ๐Ÿ‡ฒ๐Ÿ‡บ ๐Ÿ‡ฒ๐Ÿ‡ฟ ๐Ÿ‡ณ๐Ÿ‡ฆ ๐Ÿ‡ณ๐Ÿ‡ช ๐Ÿ‡ณ๐Ÿ‡ฌ ๐Ÿ‡จ๐Ÿ‡ฌ ๐Ÿ‡ท๐Ÿ‡ผ ๐Ÿ‡ธ๐Ÿ‡ณ ๐Ÿ‡ธ๐Ÿ‡ฑ ๐Ÿ‡ฟ๐Ÿ‡ฆ ๐Ÿ‡ธ๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ฌ ๐Ÿ‡บ๐Ÿ‡ฌ ๐Ÿ‡ฟ๐Ÿ‡ฒ
E ๐Ÿ‡ฆ๐Ÿ‡ฌ ๐Ÿ‡ฆ๐Ÿ‡ผ ๐Ÿ‡ง๐Ÿ‡ธ ๐Ÿ‡ง๐Ÿ‡ง ๐Ÿ‡ง๐Ÿ‡ฟ ๐Ÿ‡ป๐Ÿ‡ฌ ๐Ÿ‡จ๐Ÿ‡ผ ๐Ÿ‡ฉ๐Ÿ‡ฒ ๐Ÿ‡ฌ๐Ÿ‡ฉ ๐Ÿ‡ฌ๐Ÿ‡พ ๐Ÿ‡ญ๐Ÿ‡น ๐Ÿ‡ฏ๐Ÿ‡ฒ ๐Ÿ‡ฒ๐Ÿ‡ธ NE ๐Ÿ‡ฐ๐Ÿ‡ณ ๐Ÿ‡ฑ๐Ÿ‡จ ๐Ÿ‡ป๐Ÿ‡จ ๐Ÿ‡น๐Ÿ‡น
IL ๐Ÿ‡ฎ๐Ÿ‡ฑ
JO ๐Ÿ‡ฏ๐Ÿ‡ด
K ๐Ÿ‡ฆ๐Ÿ‡ซ ๐Ÿ‡ฆ๐Ÿ‡ฑ ๐Ÿ‡ฆ๐Ÿ‡ฉ ๐Ÿ‡ฆ๐Ÿ‡ด ๐Ÿ‡ฆ๐Ÿ‡ฎ ๐Ÿ‡ฆ๐Ÿ‡ฌ ๐Ÿ‡ฆ๐Ÿ‡ท ๐Ÿ‡ฆ๐Ÿ‡ฒ ๐Ÿ‡ฆ๐Ÿ‡ผ ๐Ÿ‡ฆ๐Ÿ‡บ ๐Ÿ‡ฆ๐Ÿ‡น ๐Ÿ‡ฆ๐Ÿ‡ฟ ๐Ÿ‡ง๐Ÿ‡ธ ๐Ÿ‡ง๐Ÿ‡ญ ๐Ÿ‡ง๐Ÿ‡ฉ ๐Ÿ‡ง๐Ÿ‡ง ๐Ÿ‡ง๐Ÿ‡พ ๐Ÿ‡ง๐Ÿ‡ช ๐Ÿ‡ง๐Ÿ‡ฟ ๐Ÿ‡ง๐Ÿ‡ฏ ๐Ÿ‡ง๐Ÿ‡ฒ ๐Ÿ‡ง๐Ÿ‡น ๐Ÿ‡ง๐Ÿ‡ด ๐Ÿ‡ง๐Ÿ‡ฆ ๐Ÿ‡ง๐Ÿ‡ผ ๐Ÿ‡ง๐Ÿ‡ท ๐Ÿ‡ฎ๐Ÿ‡ด ๐Ÿ‡ป๐Ÿ‡ฌ ๐Ÿ‡ง๐Ÿ‡ณ ๐Ÿ‡ง๐Ÿ‡ฌ ๐Ÿ‡ง๐Ÿ‡ซ ๐Ÿ‡ง๐Ÿ‡ฎ ๐Ÿ‡จ๐Ÿ‡ป ๐Ÿ‡ฐ๐Ÿ‡ญ ๐Ÿ‡จ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฆ ๐Ÿ‡ฐ๐Ÿ‡พ ๐Ÿ‡จ๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ฉ ๐Ÿ‡จ๐Ÿ‡ฑ ๐Ÿ‡จ๐Ÿ‡ณ ๐Ÿ‡จ๐Ÿ‡ฝ ๐Ÿ‡จ๐Ÿ‡จ ๐Ÿ‡จ๐Ÿ‡ด ๐Ÿ‡ฐ๐Ÿ‡ฒ ๐Ÿ‡จ๐Ÿ‡ฐ ๐Ÿ‡จ๐Ÿ‡ท ๐Ÿ‡ญ๐Ÿ‡ท ๐Ÿ‡จ๐Ÿ‡พ ๐Ÿ‡จ๐Ÿ‡ฟ ๐Ÿ‡จ๐Ÿ‡ฟ ๐Ÿ‡จ๐Ÿ‡ฎ ๐Ÿ‡จ๐Ÿ‡ฉ ๐Ÿ‡ฉ๐Ÿ‡ฐ ๐Ÿ‡ฉ๐Ÿ‡ฏ ๐Ÿ‡ฉ๐Ÿ‡ฒ ๐Ÿ‡ฉ๐Ÿ‡ด EA ๐Ÿ‡ช๐Ÿ‡จ ๐Ÿ‡ช๐Ÿ‡ฌ ๐Ÿ‡ธ๐Ÿ‡ป ๐Ÿ‡ฌ๐Ÿ‡ถ ๐Ÿ‡ช๐Ÿ‡ท ๐Ÿ‡ช๐Ÿ‡ช ๐Ÿ‡ธ๐Ÿ‡ฟ ๐Ÿ‡ช๐Ÿ‡น ET ๐Ÿ‡ซ๐Ÿ‡ฐ ๐Ÿ‡ซ๐Ÿ‡ด ๐Ÿ‡ซ๐Ÿ‡ฏ ๐Ÿ‡ซ๐Ÿ‡ฎ ๐Ÿ‡ซ๐Ÿ‡ท ๐Ÿ‡ฌ๐Ÿ‡ซ ๐Ÿ‡ต๐Ÿ‡ซ ๐Ÿ‡น๐Ÿ‡ซ ๐Ÿ‡ฌ๐Ÿ‡ฆ ๐Ÿ‡ฌ๐Ÿ‡ฒ ๐Ÿ‡ต๐Ÿ‡ธ ๐Ÿ‡ฌ๐Ÿ‡ช ๐Ÿ‡ฉ๐Ÿ‡ช ๐Ÿ‡ฌ๐Ÿ‡ญ ๐Ÿ‡ฌ๐Ÿ‡ฎ ๐Ÿ‡ฌ๐Ÿ‡ท ๐Ÿ‡ฌ๐Ÿ‡ฑ ๐Ÿ‡ฌ๐Ÿ‡ฉ ๐Ÿ‡ฌ๐Ÿ‡ต ๐Ÿ‡ฌ๐Ÿ‡น ๐Ÿ‡ฌ๐Ÿ‡ณ ๐Ÿ‡ฌ๐Ÿ‡ผ ๐Ÿ‡ฌ๐Ÿ‡พ ๐Ÿ‡ญ๐Ÿ‡น ๐Ÿ‡ญ๐Ÿ‡ฒ ๐Ÿ‡ญ๐Ÿ‡ณ ๐Ÿ‡ญ๐Ÿ‡ฐ ๐Ÿ‡ญ๐Ÿ‡บ ๐Ÿ‡ฎ๐Ÿ‡ธ ๐Ÿ‡ฎ๐Ÿ‡ณ ๐Ÿ‡ฎ๐Ÿ‡ฉ IN ๐Ÿ‡ฎ๐Ÿ‡ท ๐Ÿ‡ฎ๐Ÿ‡ถ ๐Ÿ‡ฎ๐Ÿ‡ช ๐Ÿ‡ฎ๐Ÿ‡ฑ IS ๐Ÿ‡ฎ๐Ÿ‡น ๐Ÿ‡ฏ๐Ÿ‡ฒ ๐Ÿ‡ฏ๐Ÿ‡ต ๐Ÿ‡ฏ๐Ÿ‡ด ๐Ÿ‡ฐ๐Ÿ‡ฟ ๐Ÿ‡ฐ๐Ÿ‡ช ๐Ÿ‡ฐ๐Ÿ‡ฎ KO ๐Ÿ‡ฐ๐Ÿ‡ผ ๐Ÿ‡ฐ๐Ÿ‡ฌ ๐Ÿ‡ฑ๐Ÿ‡ฆ ๐Ÿ‡ฑ๐Ÿ‡ป ๐Ÿ‡ฑ๐Ÿ‡ง ๐Ÿ‡ฑ๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ท ๐Ÿ‡ฑ๐Ÿ‡พ ๐Ÿ‡ฑ๐Ÿ‡ฎ ๐Ÿ‡ฑ๐Ÿ‡น ๐Ÿ‡ฑ๐Ÿ‡บ ๐Ÿ‡ฒ๐Ÿ‡ด ๐Ÿ‡ฒ๐Ÿ‡ฌ ๐Ÿ‡ฒ๐Ÿ‡ผ ๐Ÿ‡ฒ๐Ÿ‡พ ๐Ÿ‡ฒ๐Ÿ‡ป ๐Ÿ‡ฒ๐Ÿ‡ฑ ๐Ÿ‡ฒ๐Ÿ‡น ๐Ÿ‡ฒ๐Ÿ‡ญ ๐Ÿ‡ฒ๐Ÿ‡ถ ๐Ÿ‡ฒ๐Ÿ‡ท ๐Ÿ‡ฒ๐Ÿ‡บ ๐Ÿ‡พ๐Ÿ‡น ๐Ÿ‡ฒ๐Ÿ‡ฝ ๐Ÿ‡ซ๐Ÿ‡ฒ ๐Ÿ‡ฒ๐Ÿ‡ฉ ๐Ÿ‡ฒ๐Ÿ‡จ ๐Ÿ‡ฒ๐Ÿ‡ณ ๐Ÿ‡ฒ๐Ÿ‡ช ๐Ÿ‡ฒ๐Ÿ‡ธ ๐Ÿ‡ฒ๐Ÿ‡ฆ ๐Ÿ‡ฒ๐Ÿ‡ฟ ๐Ÿ‡ฒ๐Ÿ‡ฒ ๐Ÿ‡ณ๐Ÿ‡ฆ ๐Ÿ‡ณ๐Ÿ‡ท ๐Ÿ‡ณ๐Ÿ‡ต ๐Ÿ‡ณ๐Ÿ‡ฑ NE ๐Ÿ‡ณ๐Ÿ‡จ ๐Ÿ‡ณ๐Ÿ‡ฟ ๐Ÿ‡ณ๐Ÿ‡ฎ ๐Ÿ‡ณ๐Ÿ‡ช ๐Ÿ‡ณ๐Ÿ‡ฌ ๐Ÿ‡ณ๐Ÿ‡บ ๐Ÿ‡ณ๐Ÿ‡ซ ๐Ÿ‡ฒ๐Ÿ‡ฐ ๐Ÿ‡ณ๐Ÿ‡ด ๐Ÿ‡ด๐Ÿ‡ฒ ๐Ÿ‡ต๐Ÿ‡ฐ ๐Ÿ‡ต๐Ÿ‡ผ ๐Ÿ‡ต๐Ÿ‡ฆ ๐Ÿ‡ต๐Ÿ‡ฌ ๐Ÿ‡ต๐Ÿ‡พ ๐Ÿ‡ต๐Ÿ‡ช ๐Ÿ‡ต๐Ÿ‡ญ ๐Ÿ‡ต๐Ÿ‡ณ ๐Ÿ‡ต๐Ÿ‡ฑ ๐Ÿ‡ต๐Ÿ‡น ๐Ÿ‡ต๐Ÿ‡ท ๐Ÿ‡ถ๐Ÿ‡ฆ ๐Ÿ‡จ๐Ÿ‡ฌ ๐Ÿ‡ท๐Ÿ‡ช ๐Ÿ‡ท๐Ÿ‡ด ๐Ÿ‡ท๐Ÿ‡บ ๐Ÿ‡ท๐Ÿ‡ผ ๐Ÿ‡ธ๐Ÿ‡ญ ๐Ÿ‡ฐ๐Ÿ‡ณ ๐Ÿ‡ฑ๐Ÿ‡จ ๐Ÿ‡ต๐Ÿ‡ฒ ๐Ÿ‡ป๐Ÿ‡จ ๐Ÿ‡ผ๐Ÿ‡ธ ๐Ÿ‡ธ๐Ÿ‡ฒ ๐Ÿ‡ธ๐Ÿ‡ฆ SA ๐Ÿ‡ธ๐Ÿ‡ณ ๐Ÿ‡ท๐Ÿ‡ธ SE SE ๐Ÿ‡ธ๐Ÿ‡จ ๐Ÿ‡ธ๐Ÿ‡ฑ ๐Ÿ‡ธ๐Ÿ‡ฌ ๐Ÿ‡ธ๐Ÿ‡ฐ ๐Ÿ‡ธ๐Ÿ‡ฎ ๐Ÿ‡ธ๐Ÿ‡ง ๐Ÿ‡ธ๐Ÿ‡ด ๐Ÿ‡ฟ๐Ÿ‡ฆ ๐Ÿ‡ฐ๐Ÿ‡ท ๐Ÿ‡ธ๐Ÿ‡ธ SO SO ๐Ÿ‡ช๐Ÿ‡ธ ๐Ÿ‡ฑ๐Ÿ‡ฐ ๐Ÿ‡ธ๐Ÿ‡ฉ SU ๐Ÿ‡ธ๐Ÿ‡ท ๐Ÿ‡ธ๐Ÿ‡ฏ ๐Ÿ‡ธ๐Ÿ‡ช ๐Ÿ‡จ๐Ÿ‡ญ ๐Ÿ‡ธ๐Ÿ‡พ ๐Ÿ‡ธ๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ผ ๐Ÿ‡น๐Ÿ‡ฏ ๐Ÿ‡น๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ญ ๐Ÿ‡น๐Ÿ‡ฑ ๐Ÿ‡น๐Ÿ‡ฌ ๐Ÿ‡น๐Ÿ‡ฐ ๐Ÿ‡น๐Ÿ‡ด TR ๐Ÿ‡น๐Ÿ‡น ๐Ÿ‡น๐Ÿ‡ณ ๐Ÿ‡น๐Ÿ‡ท ๐Ÿ‡น๐Ÿ‡ฒ ๐Ÿ‡น๐Ÿ‡จ ๐Ÿ‡น๐Ÿ‡ป ๐Ÿ‡บ๐Ÿ‡ฌ ๐Ÿ‡บ๐Ÿ‡ฆ ๐Ÿ‡ฆ๐Ÿ‡ช ๐Ÿ‡ฌ๐Ÿ‡ง UN ๐Ÿ‡บ๐Ÿ‡พ ๐Ÿ‡บ๐Ÿ‡ฟ ๐Ÿ‡ป๐Ÿ‡บ ๐Ÿ‡ป๐Ÿ‡ฆ ๐Ÿ‡ป๐Ÿ‡ช ๐Ÿ‡ป๐Ÿ‡ณ ๐Ÿ‡ผ๐Ÿ‡ซ ๐Ÿ‡ต๐Ÿ‡ธ ๐Ÿ‡ช๐Ÿ‡ญ ๐Ÿ‡พ๐Ÿ‡ช ๐Ÿ‡ฟ๐Ÿ‡ฒ ๐Ÿ‡ฟ๐Ÿ‡ผ
KR ๐Ÿ‡ฐ๐Ÿ‡ท
MA ๐Ÿ‡ฒ๐Ÿ‡ฆ
OM ๐Ÿ‡ด๐Ÿ‡ฒ
P ๐Ÿ‡จ๐Ÿ‡ท ๐Ÿ‡ฉ๐Ÿ‡ด ๐Ÿ‡ธ๐Ÿ‡ป ๐Ÿ‡ฌ๐Ÿ‡น ๐Ÿ‡ญ๐Ÿ‡ณ ๐Ÿ‡ณ๐Ÿ‡ฎ
PA ๐Ÿ‡ต๐Ÿ‡ฆ
PE ๐Ÿ‡ต๐Ÿ‡ช
S ๐Ÿ‡จ๐Ÿ‡ฆ ๐Ÿ‡ฒ๐Ÿ‡ฝ
SG ๐Ÿ‡ธ๐Ÿ‡ฌ
Column 2 Rate of Duty15.4ยข/kg + 67.5%
Quota QuantityN/A
Additional DutiesN/A

Overview

This HTS category, 2925.29.20.00, specifically encompasses "Drugs" that are classified as imines and their derivatives, or salts thereof, and fall under the subcategory of "Other" within the broader classification of aromatic compounds. These are organic chemical substances characterized by the presence of an imine functional group (C=N) where the carbon atom is bonded to at least one aryl group, and they are not specifically provided for elsewhere within the imine and derivative classifications.

Distinguishing this category from its sibling, 2925.29.60.00 ("Other"), is crucial for accurate classification. While both fall under "Other" aromatic imines, this specific subheading is reserved for those substances primarily identified and used as pharmaceutical drugs, requiring specific regulatory considerations and often having distinct pharmacological properties. The sibling category would likely cover aromatic imines that are not primarily classified as drugs, such as intermediates in chemical synthesis or other industrial applications.

As this is a leaf node within the HTS structure, there are no further subcategories. Therefore, accurate classification into 2925.29.20.00 relies on definitively identifying the substance as an aromatic imine derivative or salt, and its principal use being as a drug. Importers and exporters must consult relevant drug regulatory agency listings and scientific literature to confirm the pharmacological status and application of the imported or exported chemical to ensure correct tariff treatment.

Stay Updated

Join our newsletter to get all updates of the harmonized Tariff Schedule.